Nexium and Ornithine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nexium (esomeprazole magnesium) and Ornithine (ornithine). Common drug interactions include anxiety among females and oral candidiasis among males.

The phase IV clinical study analyzes what interactions people have when they take Nexium and Ornithine. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Nexium?

Nexium has active ingredients of esomeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 245,677 Nexium users. Check the latest studies of Nexium.

What is Ornithine?

Ornithine has active ingredients of ornithine. eHealthMe is studying from 591 Ornithine users. Check the latest studies of Ornithine.



On Jul, 11, 2026

15 people who take Nexium and Ornithine together, and have interactions are studied.

Nexium and Ornithine drug interactions.

What are the common drug interactions of Nexium and Ornithine, by gender? *:

female:

  1. Anxiety
  2. Decreased appetite
  3. Dry eye (lack of adequate tears)
  4. Dry mouth
  5. Hangover
  6. Headache (pain in head)
  7. Hyperhidrosis (abnormally increased sweating)
  8. Micturition urgency (urgency to pass the urine)
  9. Nausea (feeling of having an urge to vomit)
  10. Nervousness

male:

  1. Oral candidiasis (fungal infection of mouth)
  2. Tonsillitis (inflammation of tonsil)
  3. Fatigue (feeling of tiredness)
  4. Pain
  5. Abdominal pain
  6. Application site hypersensitivity
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  9. Klebsiella sepsis (klebsiella causes a potentially fatal whole-body inflammation)
  10. Malignant neoplasm progression (cancer tumour came back)

What are the common drug interactions of Nexium and Ornithine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  3. Malignant neoplasm progression (cancer tumour came back)
  4. Pyrexia (fever)

50-59:

  1. Blood creatinine increased
  2. Blood pressure decreased
  3. Blood urea increased
  4. Body temperature increased
  5. C-reactive protein increased
  6. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Application site hypersensitivity

60+:

  1. Oral candidiasis (fungal infection of mouth)
  2. Tonsillitis (inflammation of tonsil)
  3. Hyperhidrosis (abnormally increased sweating)
  4. Micturition urgency (urgency to pass the urine)
  5. Nausea (feeling of having an urge to vomit)
  6. Nervousness
  7. Neuropathy peripheral (surface nerve damage)
  8. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Weight decreased

What are the existing conditions these people have? *

  1. Abdominal Pain Upper: 3 people, 20.00%
  2. Blood Bilirubin Increased: 3 people, 20.00%
  3. Urinary Retention (the inability to completely or partially empty the bladder): 3 people, 20.00%
  4. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 20.00%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 20.00%
  6. Reflux Laryngitis (voice disorder caused by backflow of stomach fluids to the throat and voice box area): 3 people, 20.00%
  7. Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 3 people, 20.00%
  8. Urination - Excessive At Night: 3 people, 20.00%
  9. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 20.00%
  10. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nexium and Ornithine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nexium and Ornithine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nexium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ornithine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nexium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ornithine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on esomeprazole magnesium and ornithine (the active ingredients of Nexium and Ornithine, respectively), and Nexium and Ornithine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: